Home / Sponsored Articles

Sponsored Articles

Biosimilar drug development and the importance of analytical characterization

Author: Fiona M Greer, BSc (Hons), MSc, PhD, Global Director, BioPharma Services Development, SGS Life Science Services


The development of a biosimilar requires comprehensive physicochemical characterization at many stages of the development pathway. This article reviews the steps that one must follow during the development process.  

Keywords: biosimilarity, biosimilars, head-to-head comparability, physicochemical characterization

Sourcing innovator products in the age of biosimilar research

Michael Cohen, BSc, MBA

Sourcing innovator drugs is a critical and complex component of biosimilar research. Understanding the challenges and conducting thorough upfront planning are crucial in ensuring success.

Keywords: Innovator drug sourcing challenges

Legislations on biosimilar interchangeability in the US and EU – developments far from visibility

Phani Kishore Thimmaraju, BPharm; R Rakshambikai, PhD; Raheem Farista, MPharm; Karthaveerya Juluru, MPharm

With the rising healthcare expenditure, biosimilars are projected as a cost-effective solution yet retaining clinical properties as the originator drugs. However, the true potential of biosimilars would be realized only when it attains the status of interchangeability, wherein, the two drug forms may be substituted with one another at the level of the pharmacy. The legislations that govern such substitutions are non-uniform, with only a few countries currently working towards such guidelines. Various stakeholders influence the drivers and barriers that entangle this space. The article critically evaluates different parameters and their influence on biosimilars uptake. 

Keywords: Biosimilars, interchangeability, legal issues, legislations, patient accessibility, regulations